SEE
42
-2
OXY
44
-2
EXPE
56
2
CAT
46
4
LEN
22
8
EL
43
-2
NWSA
73
3
PAYX
47
-3
KHC
13
12
MET
60
2
PNW
52
-3
MPC
39
-5
CMCSA
39
-2
VLO
50
-2
LNC
43
8
GILD
46
-10
CCI
28
3
AES
37
2
D
48
2
HUM
39
2
SEE
42
-2
OXY
44
-2
EXPE
56
2
CAT
46
4
LEN
22
8
EL
43
-2
NWSA
73
3
PAYX
47
-3
KHC
13
12
MET
60
2
PNW
52
-3
MPC
39
-5
CMCSA
39
-2
VLO
50
-2
LNC
43
8
GILD
46
-10
CCI
28
3
AES
37
2
D
48
2
HUM
39
2
Financhill
Back

Altimmune Stock Predictions

Former Zillow exec targets $1.3T marke

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Buy
57

ALT
Altimmune

Last Price:
$7.02
Seasonality Move:
3.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Notable investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa

Altimmune Stock Forecast

  • Over the next 52 weeks, Altimmune has on average historically fallen by 0.9% based on the past 19 years of stock performance.
  • Altimmune has fallen lower in 12 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.16%
  • Is Altimmune Stock Undervalued?
    The current Altimmune [ALT] share price is $6.78. The Score for ALT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • ALT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Altimmune Stock Go Up Next Year?

  • Over the next 52 weeks, Altimmune has on average historically fallen by 0.9% based on the past 19 years of stock performance.

Altimmune Stock Rating

Buy
57
Altimmune (ALT) is a Buy

Is Altimmune overpriced?

  • Altimmune has fallen lower in 12 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.16%

Altimmune Stock Price History

Is ALT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALT is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
altimmune.com

52-Week Data

52-Week High:
11.16
52-Week Low:
3.55

Prediction Charts

Market Cap:
549.9M
Price in USD:
6.78
Volume:
5.7M
Beta:
1.20

Technical Analysis

SMA50:
5.47
SMA100:
5.74
SMA200:
6.56
52-Wk Change:
14.72%

Stock Predictions

  • Is Altimmune stock public?
    Yes, Altimmune is a publicly traded company.
  • What is the Altimmune stock quote today?
    The Altimmune stock price is 6.78 USD today.
  • How to buy Altimmune stock online?
    You can buy Altimmune shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-30 5.50 5.43 5.59 5.35
Jun-2 5.46 5.30 5.52 5.15
Jun-3 5.37 5.42 5.53 5.29
Jun-4 5.39 5.49 5.57 5.34
Jun-5 5.50 5.46 5.66 5.38
Jun-6 5.48 5.62 5.81 5.47
Jun-9 5.75 5.95 5.96 5.57
Jun-10 6.07 6.74 6.97 6.05
Jun-11 6.79 6.54 7.08 6.52
Jun-12 6.50 7.15 7.48 6.38
Jun-13 6.94 6.92 7.41 6.75
Jun-16 7.09 6.87 7.37 6.79
Jun-17 6.85 6.89 6.97 6.65
Jun-18 6.88 6.78 7.20 6.61

Altimmune Earnings

Altimmune Earnings Report: Per Share Altimmune Earnings Q1 Q2 Q3 and Q4 last year and next year.

Altimmune Forecast Revenue Growth

Altimmune Stock Analysis: Historical quarterly revenues per share for Altimmune and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.08 per share, and a decrease next year of $0.29 per share.

* Altimmune stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.